Whale of a deal: Orca lands a $192M series D to study cell therapies June 17, 2020 By Lee Landenberger No Comments Orca Bio Inc.’s $192 million series D brings the company out of stealth and openly into the business of transforming allogeneic cell therapies. The new funding brings Orca’s total capital raised since 2016 to nearly $300 million. Read More